Predictive Value of 24-Hour Bilirubin in Developing Hyperbilirubinemia among Term Infants in a Multi-Center Study in the Philippines
OHRPA

Assessment of Diagnostic Algorithms and Tools for Multidrug Resistant and Drug Sensitive Tuberculosis in the Philippines Part II (TB-FIT 2)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA

Long Term outcomes of Diagnosed Tuberculosis Cases in the Philippines
National Institutes of Health - UP Manila
OHRPA

Community Approach to Control and Halt Drug-Resistant TB (COACH DRTB)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA

Prospective Urban and Rural Epidemiologic (PURE) Study
Philippine General Hospital
OHRPA

The International Polycap Study 3 (TIPS3)
Philippine General Hospital
OHRPA

The Philippine COPD Profile and Survival Study (CPASS): A Multicenter, Prospective Cohort, Observational Study
Philippine College of Chest Physicians
OHRPA

Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays: Project 5. Determination of Pharmacokinetic Properties
Pharmalytics Corporation
Tuklas Lunas

Discovery and Development of Health Products [DDHP]: Formulation, Standardization, and Metabolic Profiling of Disease-Specific Top-Tier Plants for Pre-Clinical and Clinical Development Project 2. Standardized Dosage Forms of Biologically Active Extracts Suitable for Use in Preclinical and Clinical Research: Top Tier Herbs for Diabetes, Inflammation and Cancer
Pharmalytics Corporation
Tuklas Lunas

Efficacy and Safety of Orally Administered Fixed-Dose Combination Capsule of RGA02 + JRA01 + ASB02 in the Treatment of Dengue Without Warning Signs Among Adult Filipinos in Cavite: A Randomized, Double-blind, Placebo Controlled Trial
Pharmalytics Corporation
Tuklas Lunas

REPUBLIC OF THE PHILIPPINES
All content is in the public domain unless otherwise stated.
ABOUT GOVPH
Learn more about the Philippine government, its structure,
how government works and the people behind it.
Skip to content